Delivery Order SPE2DB20D1047-SPE2DB24FF24L

The Defense Logistics Agency awarded a firm fixed price delivery order valued at $61,200 to Amerisourcebergen Drug Corporation for the supply of 100 units of 0.5 mg Repaglinide tablets. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The single day order from August 7-8, 2023 is being fulfilled under an existing indefinite-delivery/indefinite-quantity contract vehicle with the DLA, though further details regarding the base IDIQ are not provided....

The Defense Logistics Agency awarded a $306 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 tablets of 2 mg Repaglinide, an oral anti-diabetic medication. To be performed at Amerisourcebergen's facility in Conshohocken, Pennsylvania, the order is valued at three hundred six dollars and twelve cents exactly and runs from July 31, 2023 through August 1, 2023. As a leading provider of pharmaceuticals and medical supplies to the Department of Defense,...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,314.56 to supply Repaglinide 1 mg tablets (90-count units) with a completion date of December 2, 2025. This firm fixed-price contract, awarded without set-aside designation on December 1, 2025, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement for pharmaceutical products supporting federal medical supply needs. This...

The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,189.32 to AmerisourceBergen Drug Corp for the supply of Repaglinide 1 mg tablets (90-count units) under a firm fixed price contract. The award was made on November 26, 2025, with an ultimate completion date of November 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded procurement with no small...

The Defense Logistics Agency awarded a $2,702.96 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Repaglinide 1 mg, a diabetes medication, with performance in Conshohocken, Pennsylvania and completion by November 25, 2025. This non-set-aside, competitively awarded contract reflects firm fixed pricing terms typical of the agency's pharmaceutical procurement operations. AmerisourceBergen Drug Corp, headquartered in Pennsylvania, is a major pharmaceutical distributor serving...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Repaglinide 1 mg tablets in a 90-count package at a firm fixed price of $1,189.32. This is a non-set-aside, competitively awarded contract with an ultimate completion date of December 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order as a child contract under its larger Indefinite...

The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Repaglinide 1 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $4,911.34 with firm fixed pricing and an ultimate completion date of July 15, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under...

This is a delivery order issued by the Defense Logistics Agency under its pharmaceutical supply chain for Repaglinide 1 mg tablets (90-count unit), a diabetes medication. The contract was awarded to AmerisourceBergen Drug Corp on December 29, 2025, with a ceiling value of $1,189.32 under firm fixed pricing. The order is classified as a non-set-aside, competitively awarded delivery order with an ultimate completion date of December 30, 2025, and will be performed at the contractor's corporate...

The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $1,435 to Amerisourcebergen Drug Corporation to supply 120 mg tablets of nateglinide in unit doses of 30 tablets. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 8-11, 2023. This delivery order was issued against an existing DLA contract vehicle to support the agency's medical supply needs, but no additional...

The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,456.78 for 100 tablets of Nateglinide 120 mg, an oral antidiabetic medication, with a completion date of November 12, 2025. This competitively awarded, firm fixed-price contract was issued on November 10, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The award includes no set-aside designation, reflecting the contractor's demonstrated capability...